LEXINGTON, Mass., June 10, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) invites investors and the general public to its Annual Shareholders' Meeting at 5:00 p.m. ET on Wednesday, June 12, 2013. The meeting will be held at the company's headquarters located at 3 Forbes Road, Lexington, MA 02421. Registration for attendees starts at 4:30 p.m. ET. A live webcast will be accessible from the company's website at www.agenusbio.com/webcast/ and will be archived and available for replay approximately two hours after the meeting. Agenus Inc. is a biotechnology company working to develop treatments for cancers and infectious diseases. The company is focused on immunotherapeutic products based on strong platform technologies with multiple product candidates advancing through the clinic, including several product candidates that have advanced into late-stage clinical trials through corporate partners. Between Agenus and its partners, 21 programs are in clinical development. For more information, please visit www.agenusbio.com.
CONTACT: Media and Investor Contact: Jonae R. Barnes Vice President Investor Relations and Corporate Communications email@example.com 781-674-4538 Office 617-818-2985 Cell